Oxford Cannabinoid Technologies logo
Startup

Oxford Cannabinoid Technologies

See Oxford Cannabinoid Technologies's full profile

BOOK A DEMO
Headquarters

United Kingdom

Founded Year

2017

Total Funding

$10.0M

Employees

11 - 50

Status

Active


About Oxford Cannabinoid Technologies

OCT uses 21st century technology and modern drug development standards to explore the potential of cannabinoid medication and bring pioneering treatments to the market.

Headquarters

United Kingdom


General Information on Oxford Cannabinoid Technologies

Brand name Oxford Cannabinoid Technologies
Company name Oxford Cannabinoid Technologies
Website https://www.oxcantech.com/
Founded year 2017
Employees 11 - 50
Contact [email protected]
+4401865304040

Find startup solutions in your specific business context

The INNOSPOT Startup Discovery platform helps you to find the right startup solutions by leveraging the world's most powerful Startup Search Engine analyzing millions of data points.
BOOK A DEMO

Recent News and Activity about Oxford Cannabinoid Technologies

ResearchTree 10.12.2021
Oxford Cannabinoid Technologies Holdings expands its reach to US with OTCQB platform

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP) CEO John Lucas tells Proactive it has got the go-ahead for its shares to start trading on the OTCQB Market, the mid-tier OTC Equity Market in the United States. Dual trading of its shares on the London Stock Exchange's Main Market and the OTCQB market will provide enhanced investor benefits, Lucas says, making it including easier access to trading for investors based in the US and increased ...

Oxford Cannabinoid Technologies news
ResearchTree 07.12.2021
Oxford Cannabinoid Technologies collaborate with Dalriada to expand into other therapeutic areas

Dalriada has previously designed, synthesised and experimentally tested all of the compounds in the Canopy library.

Wiredfocus 01.12.2021
London's Oxford Cannabinoid Technologies to launch twin US listing

Investors were seemingly pleased with the move, as OCTP's share price surged 17.9 per cent by mid-afternoon. Landing on the US' OTC Equity Market under the ticker OCTHF, the cannabinoid pharmaceutical firm said that the new listing will open it up to a “broader pool of potential investors” which will bolster liquidity. OCTP's assured London shareholders that its ability to trade its existing ordinary shares on the London Stock Exchange's (LSE) ...

Oxford Cannabinoid Technologies news
City A.M. 01.12.2021
London’s Oxford Cannabinoid Technologies to launch twin US listing

London-listed Oxford Cannabinoid Technologies (OCTP) is set to open a twin listing in the US to ensure investors have “easier access”. Investors were seemingly pleased with the move, as OCTP’s share price surged 17.9 per cent by mid-afternoon. Landing on the US’ OTC Equity Market under the ticker OCTHF, the cannabinoid pharmaceutical firm said that the new listing will open it up to a “broader pool of potential investors” which will bolster ...

Oxford Cannabinoid Technologies news
Market Watch 01.12.2021
Oxford Cannabinoid Technologies Shares Rise on US OTC Market Listing Approval

Shares of Oxford Cannabinoid Technologies Holdings PLC rose as much as 14% in early trade Wednesday after the company said that its application for trading on the U.S. OTC QB Market has been approved. The cannabinoid-focused pharmaceutical company backed by tobacco group Imperial Brands PLC and rapper Snoop Dogg, which floated on the London Stock Exchange in May, said that the U.S. listing will provide enhanced investor benefits, including ...

Oxford Cannabinoid Technologies news
Swissquote (Switzerland) (German) 24.11.2021
BRIEF-Oxford Cannabinoid Technologies Holdings Says Gavin Sathianathan To Retire From Board With Immediate Effect

Nov 24- Oxford Cannabinoid Technologies Holdings PLC:* OXFORD CANNABINOID- DIRECTORATE CHANGE

MarketScreener 18.11.2021
Oxford Cannabinoid Technologies Holdings plc Announces New Agreement Signed with Oxford Stemtech Limited | MarketScreener

Oxford Cannabinoid Technologies Holdings plc announced that OCT has signed a new drug development agreement with Stemtech. Stemtech is a contract research organisation based in Oxford and led by Dr. Zameel Cader, which generates re-programmed human stem cells for research and drug discovery. Under the agreement Stemtech will provide OCT with cutting edge support for its drug development programmes, starting with Programmes 3 and 4 which are ...

Oxford Cannabinoid Technologies news
ResearchTree 18.11.2021
Oxford Cannabinoid Technologies in drug development deal with Oxford StemTech

Using cell technology pioneered by Professor Zameel Cader and his team, Sowemimo-Coker said the aim is to predict in the lab human responses to OCT’s cannabinoid-based treatments using re-engineered stem cells.

Proactive Investors 01.11.2021
Proactive News round-up: Oxford Cannabinoid Technologies, MGC Pharmaceuticals Ltd, Westmount, Challenger Energy …

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP) said 198.5mln of its shares, representing 20.7% of the company's issued share capital, have been pledged as security against a loan by Kingsley Capital Partners, a partnership controlled by its executive chairman, Neil Mahapatra. IXICO PLC (AIM:IXI, OTC:PHYOF) has been chosen by its largest pharma client to provide neuroimaging services for a new phase III clinical trial into demyelinating ...

Oxford Cannabinoid Technologies news
Proactive Investors USA 15.10.2021
Oxford Cannabinoid Technologies on progress since listing, including Canopy Growth Corporation deal

It captures the period that led to its stock market float on May 21, as it raised £16.5mln of new equity to fund the business’s development.The company has inked agreements with key partners for its lead cannabis drug compound as well as its drug-device/phytocannabinoid combination. It has also acquired key medical assets from Canopy Growth Corporation( TSX:WEED, NYSE:CGC ) (TSX:WEED, NYSE:CGC ), giving it an exclusive worldwide licence to their ...

Oxford Cannabinoid Technologies news